Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Clarithromycin on Apixaban PK
NCT02912234Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of apixaban in venous thromboembolism (VTE), sponsored by Bristol Myers Squibb. Primary endpoints: Maximum observed concentration, Area under the plasma concentration-time curve from time zero extrapolated to infinite time and 1 more. Started Sep 2016; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02912234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912234.